Literature DB >> 24767466

Relationship between public subsidies and vaccination rates with the 23-valent pneumococcal vaccine in elderly persons, including the influence of the free vaccination campaign after the Great East Japan Earthquake.

Toshio Naito1, Naoto Matsuda2, Mika Tanei2, Yukiko Watanabe2, Akira Watanabe3.   

Abstract

Low vaccination rates with pneumococcal vaccine in elderly persons in Japan are thought to be related to low levels of public subsidy. To identify strategies to increase future pneumococcal vaccination rates, we examined the relationship between public subsidies and vaccination rates. We also investigated the influence of free vaccinations after the 2011 Great East Japan Earthquake on vaccination rates in the three Tohoku prefectures of Japan. We surveyed a total of 1742 municipalities in Japan about whether public subsidies were available and their monetary amount. Vaccination rates with the 23-valent pneumococcal vaccine were calculated as the "cumulative amount shipped to each municipality divided by the population aged ≥65 years." There were no subsidies in 773 municipalities (44.4%). In those municipalities with public subsidies, larger subsidies were significantly associated with elevated vaccination rates (p < 0.0001). Compared to a mean vaccination rate of 25.4% throughout Japan, the vaccination rate was 52.1% in municipalities where the full cost was subsidized. The three prefectures (Iwate, Miyagi, and Fukushima) most affected by the Great East Japan Earthquake ranked as the top three prefectures for vaccination rates in Japan, presumably as a result of the free vaccination campaign for disaster victims. Our findings show that public subsidies play an important role in increasing the vaccination rate. The free vaccinations given to disaster victims after the Great East Japan Earthquake helped to achieve extremely high vaccination rates in the three Tohoku prefectures. We suggest that such public subsidies should be promoted throughout Japan.
Copyright © 2014 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Disaster; Health care costs; Pneumococcal vaccine; Public subsidies

Mesh:

Substances:

Year:  2014        PMID: 24767466     DOI: 10.1016/j.jiac.2014.03.004

Source DB:  PubMed          Journal:  J Infect Chemother        ISSN: 1341-321X            Impact factor:   2.211


  9 in total

1.  Economic Evaluation of Immunisation Programme of 23-Valent Pneumococcal Polysaccharide Vaccine and the Inclusion of 13-Valent Pneumococcal Conjugate Vaccine in the List for Single-Dose Subsidy to the Elderly in Japan.

Authors:  Shu-ling Hoshi; Masahide Kondo; Ichiro Okubo
Journal:  PLoS One       Date:  2015-10-07       Impact factor: 3.240

2.  The burden and etiology of community-onset pneumonia in the aging Japanese population: a multicenter prospective study.

Authors:  Konosuke Morimoto; Motoi Suzuki; Tomoko Ishifuji; Makito Yaegashi; Norichika Asoh; Naohisa Hamashige; Masahiko Abe; Masahiro Aoshima; Koya Ariyoshi
Journal:  PLoS One       Date:  2015-03-30       Impact factor: 3.240

3.  Factors associated with pneumococcal vaccination in elderly people: a cross-sectional study among elderly club members in Miyakonojo City, Japan.

Authors:  Akihiro Sakamoto; Charnchudhi Chanyasanha; Dusit Sujirarat; Nobuhiro Matsumoto; Masamitsu Nakazato
Journal:  BMC Public Health       Date:  2018-10-12       Impact factor: 3.295

4.  Changes in the Pneumococcal Vaccine Serotypes in Adult Noninvasive Pneumonia after the Introduction of Pneumococcal Conjugate Vaccination for Children.

Authors:  Hiroaki Takeda; Chisa Sato; Chang Bin; Midori Nishidzuka; Mari Watanabe; Tomoka Yamamoto; Hiroki Suzuki; Kazunori Oishi; Fumihiro Tsuchida
Journal:  J Glob Infect Dis       Date:  2019 Jan-Mar

5.  Preventive effects of pneumococcal and influenza vaccines on community-acquired pneumonia in older individuals in Japan: a case-control study.

Authors:  Kanzo Suzuki; Kyoko Kondo; Masakazu Washio; Kei Nakashima; Sakae Kan; Seiichiro Imai; Kunihiko Yoshimura; Chiharu Ota; Satoko Ohfuji; Wakaba Fukushima; Yoshio Hirota
Journal:  Hum Vaccin Immunother       Date:  2019-04-15       Impact factor: 3.452

6.  Factors associated with PPSV23 coverage among older adults in Japan: a nationwide community-based survey.

Authors:  Yoshitaka Murakami; Shinichi Kanazu; Tanaz Petigara; Mari Saito Oba; Yuji Nishiwaki; Akira Watanabe
Journal:  BMJ Open       Date:  2019-07-16       Impact factor: 2.692

7.  Public subsidies and the recommendation of child vaccines among primary care physicians: a nationwide cross-sectional study in Japan.

Authors:  Yuta Sakanishi; Yosuke Yamamoto; Megumi Hara; Norio Fukumori; Yoshihito Goto; Tesshu Kusaba; Keitaro Tanaka; Takashi Sugioka; Japan Primary Care Association Vaccine Project Team; Shunichi Fukuhara
Journal:  BMJ Open       Date:  2018-07-19       Impact factor: 2.692

8.  Archetype analysis of older adult immunization decision-making and implementation in 34 countries.

Authors:  Lois Privor-Dumm; Prarthana Vasudevan; Kana Kobayashi; Jaya Gupta
Journal:  Vaccine       Date:  2020-04-16       Impact factor: 3.641

9.  Safety and Efficacy of Simultaneous Inoculations of Pneumococcal and Influenza Vaccines in Patients with Coronary Artery Disease.

Authors:  Kazunori Shimada; Hiroaki Morinaga; Takashi Kiyanagi; Tetsuro Miyazaki; Miho Nishitani-Yokoyama; Iwao Okai; Hiroshi Tamura; Hakuoh Konishi; Takeshi Kurata; Katsumi Miyauchi; Hiroyuki Daida
Journal:  J Atheroscler Thromb       Date:  2020-10-15       Impact factor: 4.928

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.